Tomohiro Kato

Tomohiro Kato

Auto-generated profile, based on publicly available information

Tomohiro Kato

Centre for Preventive Medicine, The Jikei University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
YNYutaka Nakao
Yutaka Nakao
SSShoichi Saito
Shoichi Saito
TOTomohiko Ohya
Tomohiko Ohya
HAHiroyuki Aihara
Hiroyuki Aihara
SASeiji Arihiro
Seiji Arihiro
HTHisao Tajiri
Hisao Tajiri
To clarify of the features of sessile serrated adenoma/polyp (SSA/P) observed with image-enhanced endoscopy using immunohistochemical staining. Twenty-five hyperplastic polyps (HP) and 46 SSA/P were studied with autofluorescence imaging (AFI) and magnifying endoscopy with narrow-band imaging (ME-NBI). AFI color change, capillary dilatation, existence of a mucous layer on the tumor surface, and pit dilatation under ME-NBI were examined retrospectively. Immunohistochemical staining was performed with the proliferation-associated antigen MIB-1 (Ki-67). Using AFI, a magenta color was observed in 32% of HP and 44% of SSA/P. With NBI observation, capillary dilatation was observed in 4% of HP and 11% of SSA/P, a mucous cap was observed in 60% of HP and 94% of SSA/P, and pit dilatation was observed in 28% of HP and 80% of SSA/P. When magenta color, capillary dilatation, mucous cap, and pit dilatation were used for the differential diagnosis of SSA/P from HP, the sensitivity, specificity, and accuracy were 43, 68, and 52% for AFI, respectively, 10, 96, and, 41% for capillary dilatation, respectively, 94, 40, and 75% for mucous cap, respectively, and 80, 72, and 78% for pit dilatation, respectively. Compared with HP, MIB-1-positive cells were more frequently distributed in the gland's intermediate zone in SSA/P. The biological malignant potential of SSA/P could be higher compared with HP as suggested by the MIB-1 stain. Therefore, endoscopic differentiation of SSA/P from HP is important, and the findings of a mucous cap and dilatated pit might be helpful for the differentiation of SSA/P from HP.

15 February 2016 in Endoscopy
Verified
Journal Article
Closed access
PDF file
KGKenichi Goda
Kenichi Goda
ADAkira Dobashi
Akira Dobashi
NYNoboru Yoshimura
Noboru Yoshimura
HAHiroyuki Aihara
Hiroyuki Aihara
MKMasayuki Kato
Masayuki Kato
HTHisao Tajiri
Hisao Tajiri
Background and study aims: Conventional magnification narrow-band imaging (CM-NBI) endoscopy has demonstrated high diagnostic accuracy for superficial squamous neoplasms in the pharynx and esophagus. This study aimed to evaluate the diagnostic utility of the newly developed dual-focus NBI (DF-NBI) compared with that of CM-NBI. Patients and methods: We recruited patients with squamous cell carcinoma (SCC) in the head and neck, or esophagus, or with a history of SCC. The primary endpoint of this prospective controlled non-inferiority trial was the sensitivity of DF-NBI and CM-NBI for detecting superficial carcinoma in the pharynx and esophagus. Secondary endpoints included other diagnostic values and the resolving power of each endoscope. Superficial carcinoma was defined as high grade dysplasia and SCC invading up to the submucosal layer. Results: The study included 93 patients. A total of 28 superficial carcinomas were detected in the pharynx and esophagus. The sensitivities of DF-NBI and CM-NBI for superficial carcinoma were 82 % and 71 %, respectively. The lower limit of the 90 % confidence interval for the difference between the sensitivities exceeded the non-inferiority threshold. The specificity and overall accuracy of DF-NBI vs. CM-NBI were 93 % vs. 90 % and 91 % vs. 86 %, respectively (both non-significant differences). The maximum resolving power of a conventional magnification endoscope was significantly higher than a dual-focus endoscope (7.2 µm vs. 11.6 µm: P < 0.001). Conclusions: The findings indicate the non-inferiority of DF-NBI versus CM-NBI in detecting superficial carcinoma in the pharynx and esophagus. DF-NBI appears to have a resolving power that, although significantly lower, is sufficient to achieve high diagnostic accuracy, comparable to that of CM-NBI. University Hospital Medical Information Network (UMIN, No. 000007585).

15 June 2010 in Endoscopy
Verified
Journal Article
Closed access
KSKazuki Sumiyama
Kazuki Sumiyama
HTH. Tajiri
H. Tajiri
CGC. J. Gostout
C. J. Gostout
MKM. Kawamura
M. Kawamura
HIHiroo Imazu
Hiroo Imazu
TKT. Kato
T. Kato
Background and study aims: A randomized in vivo animal study previously demonstrated that topical injection of mesna solution (sodium-2-mercaptoethanesulfonate) chemically softened submucosal connective tissues and facilitated mechanical dissection of the submucosal tissue plane. The present study evaluated the technical feasibility and safety of chemically assisted endoscopic submucosal dissection (CA-ESD) using mesna in 20 consecutive patients who underwent endoscopic excision of gastric neoplasm. Materials and methods: Following the margination of the lesion with a mucosal circumcision, 4 – 12 mL of 10 % mesna solution was injected into the submucosal layer. Mechanical submucosal dissection was then performed by bluntly cleaving the chemically treated submucosal layer with the tip of a cap-fitted gastroscope. The use of cautery was restricted to prophylactic hemostasis, dissection of the coagulated vessels and persistent submucosal tissues, and the final snare resection. Post-therapeutic ulceration repair and adverse events were followed up during a 1-week hospitalization and by repeat endoscopies at 1 day, 1 week, and 1 month after the procedure. Results: Sixteen gastric cancers and four adenomas were treated in this study. The sampled tissue measured 38.25 ± 14.53 mm, with an en bloc resection rate of 100 %. Mean operation time was 21.17 ± 11.6 minutes. The time spent using cautery was limited to 26.1 % of the total submucosal dissection time. Ulcerations healed normally without complications. Conclusions: This preliminary study demonstrates that submucosal injection of mesna facilitates and expedites mechanical submucosal dissection. The major limitations in this study include the single-arm study design and a small patient population.

9 February 2006 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
HNHiroshi Nakamura
Hiroshi Nakamura
MTMichiaki Tanaka
Michiaki Tanaka
KMKayo Masuko
Kayo Masuko
KYKazuo Yudoh
Kazuo Yudoh
TKTomohiro Kato
Tomohiro Kato
KNKusuki Nishioka
Kusuki Nishioka

14 February 2017 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
MKMasaki Kato
Masaki Kato
SHSusumu Hamada-Tsutsumi
Susumu Hamada-Tsutsumi
COChiaki Okuse
Chiaki Okuse
ASAiko Sakai
Aiko Sakai
NMNobuyuki Matsumoto
Nobuyuki Matsumoto
MKManae Suzuki Kurokawa
Manae Suzuki Kurokawa

1 January 2012 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
SASeiji Arihiro
Seiji Arihiro
TKTomohiro Kato
Tomohiro Kato
KIKyoko Ito
Kyoko Ito
MSMasayuki Saruta
Masayuki Saruta
TNToshiki Nikami
Toshiki Nikami
HTHisao Tajiri
Hisao Tajiri
We investigated the correlation between symptomatic improvement and quality of life in Japanese gastroesophageal reflux disease patients with PPI. Eighty one patients with reflux and dyspeptic symptom were enrolled. The evaluation of the symptom was used he Frequency Scale for the Symptom of GERD in 3 categories: total score of 12 questions, score related to reflux symptoms, and score related to dyspeptic symptoms and the evaluation of the quality of life was use the 8-item Short Form Health Survey in 2 categories, the physical component summary score and mental component summary score. All patients administered rabeprazole 10 mg/day for 8 weeks. We investigated the correlation between symptomatic improvement with proton pump inhibitor and quality of life. Significant symptomatic improvement was seen in the total score of 12 questions (26.7 ± 8.8 → 17.5 ± 5.9, p<0.0001), score related to reflux symptoms (14.9 ± 5.4 → 9.6 ± 3.6, p<0.0001), and score related to dyspeptic symptoms (11.8 ± 4.3 → 8.0 ± 2.9, p<0.0001). Significant improvement in quality of life was seen in the physical component summary score (47.8 ± 6.6 → 50.0 ± 5.9, p = 0.0209) and mental component summary score (47.4 ± 8.5 → 50.4 ± 5.3, p = 0.0133) with proton pump inhibitor. With proton pump inhibitor, a significant positive correlation was seen between the improvement rates in total score of 12 questions, score related to dyspeptic symptoms and in mental component summary score at 8 weeks (total score of 12 questions: r = 0.275, p = 0.0265, score related to dyspeptic symptoms: r = 0.367, p = 0.0027). In conclusion, quality of life was associated with improvement in dyspeptic symptoms with proton pump inhibitor treatment.